Guarini S, Bazzani C, Botticelli A, Balugani A, Bertolini A
Department of Biomedical Sciences, University of Modena, Italy.
J Pharm Pharmacol. 1996 Apr;48(4):407-10. doi: 10.1111/j.2042-7158.1996.tb05942.x.
The antithrombotic activity of a 2-kDa heparin fragment was studied in a rat model of common carotid artery thrombosis that causes a completely occlusive thrombus with cessation of the blood flow within 10-15 min. The compound reduced thrombus formation in a dose-dependent manner, starting from an intravenous dose of 5 mg kg-1. A dose of 20 mg kg-1 completely prevented thrombus formation and apparently induced the almost complete lysis of the already formed occlusive thrombus. At none of the doses used did the compound cause increased bleeding or the formation of haematomas. The present results indicate that low molecular weight heparins, which have an established, highly beneficial effect in venous thromboembolism, are also highly effective in an animal model of arterial thrombosis.
在大鼠颈总动脉血栓形成模型中研究了一种2 kDa肝素片段的抗血栓活性,该模型可导致完全闭塞性血栓,在10 - 15分钟内血流停止。该化合物从静脉注射剂量5 mg kg-1开始,以剂量依赖方式减少血栓形成。20 mg kg-1的剂量可完全防止血栓形成,并明显诱导已形成的闭塞性血栓几乎完全溶解。在所使用的任何剂量下,该化合物均未导致出血增加或血肿形成。目前的结果表明,在静脉血栓栓塞中已确立具有高度有益作用的低分子量肝素,在动脉血栓形成动物模型中也非常有效。